Abnormal expression of CUX1 influences autophagy activation in paroxysmal nocturnal hemoglobinuria

被引:0
|
作者
Wu, Junshu [1 ,2 ]
Li, Liyan [1 ,2 ]
Liu, Zhaoyun [1 ,2 ]
Wang, Honglei [1 ,2 ]
Chen, Yingying [1 ,2 ]
Zeng, Lijie [1 ,2 ]
Wang, Guanrou [1 ,2 ]
Liu, Hui [1 ,2 ]
Fu, Rong [1 ,2 ]
机构
[1] Tianjin Med Univ Gen Hosp, Dept Hematol, 154 Anshan St, Tianjin 300052, Peoples R China
[2] Tianjin Key Lab Bone Marrow Failure & Malignant He, 154 Anshan St, Tianjin 300052, Peoples R China
基金
中国国家自然科学基金;
关键词
AKT; autophagy; CUX1; mTOR; PI3K; PIGA; PNH; GENE; RESISTANCE; APOPTOSIS; MUTATIONS;
D O I
10.1093/jleuko/qiae008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mechanism underlying autophagy in paroxysmal nocturnal hemoglobinuria (PNH) remains largely unknown. We previously sequenced the entire genome exon of the CD59- cells from 13 patients with PNH and found genes such as CUX1 encoding Cut-like homeobox 1. Peripheral blood samples from 9 patients with PNH and 7 healthy control subjects were obtained to measure CUX1 expression. The correlation between CUX1 messenger RNA expression and PNH clinical indicators was analyzed. To simulate CUX1 expression in patients with PNH, we generated a panel of PNH cell lines by knocking out PIGA in K562 cell lines and transfected lentivirus with CUX1. CCK-8 and EDU assay assessed cell proliferation. Western blotting was used to detect Beclin-1, LC3A, LC3B, ULK1, PI3K, AKT, p-AKT, mTOR, and p-mTOR protein levels. Autophagosomes were observed with transmission electron microscopy. Chloroquine was used to observe CUX1 expression in PNH after autophagy inhibition. Leukocytes from patients with PNH had lower levels of CUX1 messenger RNA expression and protein content than healthy control subjects. The lactose dehydrogenase level and the percentage of PNH clones were negatively correlated with CUX1 relative expression. We reduced CUX1 expression in a PIGA knockout K562 cell line, leading to increased cell proliferation. Levels of autophagy markers Beclin-1, LC3B, LC3A, and ULK1 increased, and autophagosomes increased. Furthermore, PI3K/AKT/mTOR protein phosphorylation levels were lower. CUX1 expression did not change and cell proliferation decreased in CUX1 knocked down PNH cells after inhibition of autophagy by chloroquine. In brief, CUX1 loss-of-function mutation resulted in stronger autophagy in PNH. Loss-of-function mutation in the CUX1 gene results in relatively stronger autophagy in paroxysmal nocturnal hemoglobinuria.
引用
收藏
页码:926 / 934
页数:9
相关论文
共 50 条
  • [31] KINETIC PARAMETERS OF COMPLEMENT ACTIVATION IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DURING ECULIZUMAB THERAPY
    Tarasova, Yu, V
    Klimova, O. U.
    Andreeva, L. A.
    Vasina, L. V.
    Galebskaya, L., V
    Babenko, E., V
    Kulagin, A. D.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2020, 65 (02): : 126 - 137
  • [32] Autocrine Activation of the Wnt/β-Catenin Pathway by CUX1 and GLIS1 in Breast Cancers
    Vadnais, Charles
    Shooshtarizadeh, Peiman
    Rajadurai, Charles V.
    Lesurf, Robert
    Hulea, Laura
    Davoudi, Sayeh
    Cadieux, Chantal
    Hallett, Michael
    Park, Morag
    Nepveu, Alain
    BIOLOGY OPEN, 2014, 3 (10): : 937 - 946
  • [33] EXPRESSION OF CRYPTANTIGEN TH ON PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA ERYTHROCYTES IN ASSOCIATION WITH A HEMOLYTIC EXACERBATION
    NAKAKUMA, H
    HIDAKA, M
    NAGAKURA, S
    NISHIMURA, Y
    IWAMOTO, N
    HORIKAWA, K
    KAWAGUCHI, T
    KAGIMOTO, T
    TAKATSUKI, K
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01): : 201 - 206
  • [34] Expression of HMGA2 in Blood Cells from Patients with Paroxysmal Nocturnal Hemoglobinuria
    Murakami, Yoshiko
    Ohta, Rieko
    Inoue, Norimitsu
    Noji, Hideyoshi
    Shichishima, Tsutomu
    Nishimura, Jun-Ichi
    Kanakura, Yuzuru
    Kinoshita, Taroh
    BLOOD, 2008, 112 (11) : 1179 - 1180
  • [35] Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria
    Karadimitris, A
    Manavalan, JS
    Thaler, HT
    Notaro, R
    Araten, DJ
    Nafa, K
    Roberts, IAG
    Weksler, ME
    Luzzatto, L
    BLOOD, 2000, 96 (07) : 2613 - 2620
  • [36] Comparison of Dombrock, DAF and MIRL proteins expression on RBC of patients with paroxysmal nocturnal hemoglobinuria
    Baleotti, W
    Halverson, GR
    Saad, S
    Fabron, A
    Fukasawa, JT
    Castilho, L
    TRANSFUSION, 2005, 45 (03) : 133A - 133A
  • [37] Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria
    Endo, M
    Ware, RE
    Vreeke, TM
    Singh, SP
    Howard, TA
    Tomita, A
    Holguin, MH
    Parker, CJ
    BLOOD, 1996, 87 (06) : 2546 - 2557
  • [38] Expression of HMGA2 In Blood Cells From Patients with Paroxysmal Nocturnal Hemoglobinuria
    Murakami, Yoshiko
    Inoue, Norimitsu
    Shichishima, Tsutomu
    Noji, Hideyoshi
    Nishimura, Jun-Ichi
    Kanakura, Yuzuru
    Kinoshita, Taroh
    BLOOD, 2010, 116 (21) : 1722 - 1723
  • [39] MHC CLASS II EXPRESSION ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    Nowak, Jacek
    Wozniak, Jolanta
    Mendek-Czajkowska, Ewa
    Mika-Witkowska, Renata
    Dlugokecka, Agnieszka
    Marosz-Rudnicka, Anna
    Kopec-Szlezak, Joanna
    TISSUE ANTIGENS, 2012, 79 (06): : 580 - 581
  • [40] High expression of the Wilms tumor WT1 gene RNA in patients with paroxysmal nocturnal hemoglobinuria (PNH).
    Ikeda, K
    Shichishima, T
    Okamoto, M
    Maruyama, Y
    BLOOD, 2001, 98 (11) : 222A - 222A